During the past decade, Northeast Oncology Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northeast Oncology Associates" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 23 trials, followed by "SWOG Cancer Research Network" with 2 trials sponsored, "Duke University" with 1 trials sponsored, "Eastern Cooperative Oncology Group" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northeast Oncology Associates" #1 collaborator was "National Cancer Institute (NCI)" with 27 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "Eastern Cooperative Oncology Group" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Northeast Oncology Associates" are "Lung Cancer" (7 trials), "Lymphoma" (5 trials), "Breast Cancer" (4 trials), "Colorectal Cancer" (4 trials) and "Extragonadal Germ Cell Tumor" (2 trials). Many other conditions were trialed in "Northeast Oncology Associates" in a lesser frequency.

Most popular intervention types in "Northeast Oncology Associates" are "Drug" (24 trials), "Procedure" (7 trials), "Biological" (5 trials), "Radiation" (4 trials) and "Genetic" (2 trials). Other intervention types were less common.

The name of intervention was led by "gemcitabine hydrochloride" (6 trials), "carboplatin" (4 trials), "cisplatin" (4 trials), "cyclophosphamide" (4 trials) and "etoposide" (4 trials). Other intervention names were less common.

The vast majority of trials in "Northeast Oncology Associates" are 22 trials for "All" genders, 4 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Northeast Oncology Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Northeast Oncology Associates, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Northeast Oncology Associates, 1 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".